AU-18069

N/A

Report date: 2024/01/25 14:20:26
NME

Base Information

Drug NameAU-18069
Drug Alias NameAU-18069
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Actionp300-CBP transcription factors inhibitors
Targetsp300-CBP transcription factors
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIndia
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAurigene Discovery Technologies (Malaysia) Sdn Bhd
China Registration ClassN/A

Develop Information

Active CompaniesAurigene Discovery Technologies Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A